Table 4 The risk score of each independent prognostic factor.

From: A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER database

Characteristics

Points

Age at diagnosis

 < 40

0

 40–65

7

 > 65

100

T stage

 T1

0

 T2

26

 T3–T4

89

N stage

 N0

0

 N1–N3

44

Subtype

 TNBC

54

 HER2-enriched

28

 Luminal A

0

 Luminal B

21

Radiation

 No

66

 Yes

0

  1. HER2 human epidermal growth factor receptor 2, TNBC triple-negative breast cancer.
Back to article page